Nobuyuki Tai Selected Research

N- ((4- (biphenyl- 2- ylmethoxy)- 1- (2- (4- fluorobenzoyl)benzoyl)pyrrolidin- 2- yl)methyl)- 4- ((2,4- dioxothiazolidin- 5- ylidene)methyl)benzamide

1/2010

Cytosolic phospholipase A2 alpha inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuyuki Tai Research Topics

Disease

1	Autoimmune Diseases (Autoimmune Disease) 03/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2019
1	Inflammation (Inflammations) 03/2019
1	Vascular Calcification 01/2019
1	Osteoporosis 01/2019
1	Neoplasms (Cancer) 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2015
1	Arthritis (Polyarthritis) 01/2010
1	Experimental Arthritis 01/2010
1	Rheumatoid Arthritis 01/2010
1	Ataxia (Dyssynergia) 06/2005
1	Conjunctivitis 04/2002
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 04/2002

Drug/Important Bio-Agent (IBA)

1	S18-000003IBA 03/2019
1	Interleukin-17 (Interleukin 17)IBA 03/2019
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 03/2019
1	InterleukinsIBA 03/2019
1	OsteoprotegerinIBA 01/2019
1	CalciumIBA 01/2018
1	GoldIBA 07/2015
1	N- ((4- (biphenyl- 2- ylmethoxy)- 1- (2- (4- fluorobenzoyl)benzoyl)pyrrolidin- 2- yl)methyl)- 4- ((2,4- dioxothiazolidin- 5- ylidene)methyl)benzamideIBA 01/2010
1	Group IV Phospholipases A2IBA 01/2010
1	Zolpidem (Ambien)FDA LinkGeneric 06/2005
1	Histamine (Histamine Dihydrochloride)FDA Link 04/2002
1	OvalbuminIBA 04/2002
1	P-SelectinIBA 04/2002

Therapy/Procedure

1	Topical Administration 03/2019